Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine

The emergence of rapidly spreading variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a major challenge to vaccines’ protective efficacy. Intramuscular (IM) vaccine administration induces short-lived immunity but does not prevent infection and transmission. New vaccinatio...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, Noam Erez, Hadas Tamir, Liat Bar-On, Julia Ryvkin, Dena Leshkowitz, Ofir Israeli, Shay Weiss, Amir Ben-Shmuel, Moria Barlev-Gross, Lilach Cherry Mimran, Hagit Achdout, Nir Paran, Tomer Israely
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-05-01
Saila:	Vaccines
Gaiak:	SARS-CoV-2 vaccine nasal vaccination immunity VSV–∆G–spike mucosal vaccination
Sarrera elektronikoa:	https://www.mdpi.com/2076-393X/12/5/491
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!